Methods and trials of treatment of subjects with removal, mutation or reduced expression of SHANK3

• 收藏
• 分享

专利权人:

Icahn School of Medicine at Mount Sinai

发明人:

BUXBAUM, Joseph,SAKURAI, Takeshi,GUNAL, Ozlem

申请号：

ES11783855

公开号：

ES2617309T3

申请日:

2011.05.16

申请国别(地区):

ES

年份:

2017

代理人:

摘要：

Insulin-like growth factor 1 (IGF-1) or an active IGF-1 fragment, such as tripeptide (1-3) IGF-1, for use in the treatment of Phelan-McDermid syndrome.Factor de crecimiento de tipo insulina 1 (IGF-1) o un fragmento de IGF-1 activo, tal como el tripéptido (1-3)IGF-1, para su uso en el tratamiento del síndrome de Phelan-McDermid.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/